Yu Chang-qing, Huang Nai-yan, Zhao Hai-ying, Dou Xiao-ming, Li Jia-ze
Molecular Photonics Laboratory, Physics Department, Shanghai Jiaotong University, Shanghai 200030, China.
Guang Pu Xue Yu Guang Pu Fen Xi. 2004 Feb;24(2):138-41.
Since the selectivity of photodynamic therapy (PDT) depends on the distribution of a photosensitizer in a tissue during the treatment, an investigation of drug distribution is a key step for performing PDT effectively. The distribution of photosensitizer absorbed in tissues is adjusted by the animal body system, so an apparatus that can measure the fluorescence intensity of photosensitizer in different tissues of the same body simultaneously is in demand. To achieve precise estimate of tissue selectivity of the photosensitizer, a spatially separated three-channel laser-induced fluorescence (LIF) detection system was set up and employed in the present study to measure the fluorescence intensity of Hematoporphyrin Monomethyl Ether (HMME) in different tissues of the same body simultaneously. The time-dependent variations in the concentrations of HMME within the skin,cartilage, normal synovium and inflammatory synovium of rabbit were monitored in vivo. The results obtained showed that the synovium has higher absorptivity of HMME thanthe skin and cartilage. The difference is distinct from the very beginning of injection. Although the quantity of HMME absorbed in the inflammatory synovium is not very high in the first 20 min, it is still 6 times higher than that in the skin and cartilage. In addition, the absorptivity of HMME is much stronger for the inflammatory synovium than that for the normal synovium. If thelaser beam irradiates outside the joint for the rheumatoid arthritis, tissues around the inflammatory synovium have less HMME, thereby causing weak PDT effect. This would help reduce the side effect of PDT. Thus we suggest that for PDT treated rheumatoid arthritis, taking the first 20 min after the injection for outside-the-joint excitation employing HMME maybe a good choice.
由于光动力疗法(PDT)的选择性取决于治疗过程中组织内光敏剂的分布,因此研究药物分布是有效实施光动力疗法的关键步骤。组织中吸收的光敏剂分布受动物身体系统调节,因此需要一种能够同时测量同一动物不同组织中光敏剂荧光强度的设备。为了精确评估光敏剂的组织选择性,本研究建立并采用了一种空间分离的三通道激光诱导荧光(LIF)检测系统,以同时测量同一动物不同组织中血卟啉单甲醚(HMME)的荧光强度。在体内监测了兔皮肤、软骨、正常滑膜和炎性滑膜中HMME浓度随时间的变化。结果表明,滑膜对HMME的吸收率高于皮肤和软骨。从注射一开始这种差异就很明显。虽然在最初20分钟内炎性滑膜中吸收的HMME量不是很高,但仍比皮肤和软骨中的高6倍。此外,HMME对炎性滑膜的吸收率比对正常滑膜的吸收率强得多。如果激光束照射类风湿性关节炎关节外,炎性滑膜周围组织中的HMME较少,从而导致光动力疗法效果较弱。这将有助于减少光动力疗法的副作用。因此我们建议,对于光动力疗法治疗的类风湿性关节炎,注射后最初20分钟采用HMME进行关节外激发可能是一个不错的选择。